PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för (+)-SKF-10,047. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

12 hits

Bibliografisk träff 2016-05-26

Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

Halberstadt AL, Hyun J, Ruderman MA, Powell SB.

Pharmacol Biochem Behav · research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.pbb.2016.05.009

Bibliografisk träff 2012-01-01

Effects of (+) SKF 10,047, a sigma-1 receptor agonist, on anxiety,tested in two laboratory models in mice.

Navarro JF, Beltrán D, Cavas M.

Psicothema · journal article

Bibliografisk träff 1996-08-01

(+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress via dopaminergic systems linked to phenytoin-regulated sigma 1 sites.

Kamei H, Kameyama T, Nabeshima T.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/0014-2999(96)00346-9

Bibliografisk träff 1996-03-01

(+)-SKF-10,047 and dextromethorphan ameliorate conditioned fear stress through the activation of phenytoin-regulated sigma 1 sites.

Kamei H, Kameyama T, Nabeshima T.

Eur J Pharmacol · comparative study; journal article · DOI 10.1016/0014-2999(95)00830-6

Bibliografisk träff 1995-07-01

Intrahippocampal administration of (+)-SKF 10,047, a sigma ligand, reverses MK-801-induced impairment of working memory in rats.

Ohno M, Watanabe S.

Brain Res · journal article · DOI 10.1016/0006-8993(95)00489-d

Bibliografisk träff 1992-09-01

Neuroprotective mechanism of (+)SKF 10,047 in vitro and in gerbil global brain ischemia.

Lysko PG, Yue TL, Gu JL, Feuerstein G.

Stroke · journal article · DOI 10.1161/01.str.23.9.1319

Bibliografisk träff 1992-03-01

Effect of haloperidol and clozapine on (+)SKF 10,047-induced dopamine release: role of 5-HT3 receptors.

Volonté M, Ceci A, Borsini F.

Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(92)90250-8

Bibliografisk träff 1992-03-01

Neuroprotective effects of SKF 10,047 in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Lysko PG, Gagnon RC, Yue TL, Gu JL, Feuerstein G.

Stroke · journal article · DOI 10.1161/01.str.23.3.414

Bibliografisk träff 1990-08-01

A comparison of the psychopharmacological profiles of phencyclidine, ketamine and (+) SKF 10,047 in the trimethyltin rat model.

Earley B, Burke M, Leonard BE, Gouret CJ, Junien JL.

Neuropharmacology · comparative study; journal article · DOI 10.1016/0028-3908(90)90121-7

Bibliografisk träff 1990-01-01

Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).

Singh L, Wong EH, Kesingland AC, Tricklebank MD.

Br J Pharmacol · research-article; journal article · DOI 10.1111/j.1476-5381.1990.tb14668.x

Bibliografisk träff 1989-12-01

Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.

Marquis KL, Paquette NC, Gussio RP, Moreton JE.

J Pharmacol Exp Ther · comparative study; research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0022-3565(25)21060-6

Bibliografisk träff 1989-01-01

Effects of acute and chronic administration of (+)SKF 10,047 on body temperature in the rat.

Bejanian M, Pechnick RN, George R.

NIDA Res Monogr · research support, u.s. gov't, p.h.s.; journal article